Charting a course for better pneumococcal vaccines

Vaccine Insights 2024; 3(1), 7–12

DOI: 10.18609/vac.2024.003

Published: 26 January
Richard Malley

A new platform for developing bacterial vaccines—the multiple antigen presenting system—could enable an affordable alternative to current pneumococcal conjugate vaccines. Here, the multiple antigen presenting system co-inventor Rick Malley, Senior Physician in Pediatrics, Boston Children’s Hospital, and Professor of Pediatrics, Harvard Medical School, speaks with Charlotte Barker, Editor, Vaccine Insights, about the fast-evolving pneumococcal vaccine field.